Mikael Eriksson
11 – 20 of 151
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy : Results from the EUROpean Bone Over 40 Sarcoma Study
(
- Contribution to journal › Article
-
Mark
Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
(
- Contribution to journal › Article
-
Mark
Epithelioid hemangioendothelioma, an ultra-rare cancer : a consensus paper from the community of experts
(
- Contribution to journal › Scientific review
-
Mark
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
(
- Contribution to journal › Article
- 2020
-
Mark
Rare cancers of unknown etiology : lessons learned from a European multi-center case–control study
(
- Contribution to journal › Article
-
Mark
Sarcoma European and Latin American Network (SELNET) Recommendations on Prioritization in Sarcoma Care During the COVID-19 Pandemic
(
- Contribution to journal › Article
-
Mark
Survival Outcomes Associated with 3 Years vs 1 Year of Adjuvant Imatinib for Patients with High-Risk Gastrointestinal Stromal Tumors : An Analysis of a Randomized Clinical Trial after 10-Year Follow-up
(
- Contribution to journal › Article
- 2019
-
Mark
Tobacco smoking and alcohol consumption as risk factors for thymoma – A European case-control study
(
- Contribution to journal › Article
-
Mark
Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort
(
- Contribution to journal › Article
-
Mark
Mitotic Count and Estimation of the Risk of GIST Recurrence in Patients Treated with Preoperative Imatinib
(
- Contribution to journal › Debate/Note/Editorial